2009 Vienna - European Society of Human Genetics
2009 Vienna - European Society of Human Genetics
2009 Vienna - European Society of Human Genetics
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
Keyword Index<br />
Joubert syndrome- JSRD: C03.1<br />
Joubert syndrome: C03.2<br />
JPH3 gene: P12.089<br />
JPS: P12.100<br />
Juvenile Huntington disease: P02.055<br />
juvenile idiopathic arthritis: P09.034,<br />
P09.035<br />
juvenile rheumatoid arthritis: P14.23<br />
K<br />
K562 cells: P11.029<br />
K600fs: P16.13<br />
Kabuki syndrome: P02.057<br />
kabuki: P02.056<br />
Karak syndrome: P12.101<br />
Karyotype: P03.005, P03.037, P03.046,<br />
P03.119, P03.190, P04.09<br />
karyotyping: P03.001, P03.134, P04.23,<br />
P06.103<br />
Kashin-Beck: P09.065<br />
Kawasaki disease: P10.49<br />
kayaking: P09.066<br />
KB: P15.06<br />
KCNH2: P16.19, P16.29<br />
KCNQ1: C10.1, P16.19, P17.05<br />
KCNQ2: P17.70<br />
keratin: C12.5<br />
keratinocytes: P06.046<br />
Keratosis Follicularis Spinularis Decalvans:<br />
P12.102<br />
kermanshah: P12.010<br />
ketone body: P11.057<br />
KFSD: P12.102<br />
Khanty: P10.90<br />
kidney: P02.085<br />
KIF2A: P03.117<br />
kinship: P10.50<br />
kit: P11.062<br />
Klinefelter syndrome: P02.032, P03.038<br />
Knobloch syndrome: P02.058, P02.059<br />
knock-down: C11.6<br />
knockout mouse: P06.085<br />
KORA: P17.05<br />
kRAS: P06.155, P06.205, P06.206,<br />
P06.207<br />
KRT5,KRT14: P02.036<br />
L<br />
laboratory <strong>of</strong> Leningrad province: P01.36<br />
laboratory parameters: P05.08<br />
laboratory techniques: P01.49<br />
LAMA2 gene: P11.063<br />
LAMA2: P16.39<br />
LARC: P11.040<br />
large rearrangement: P06.112, P06.159,<br />
P12.160<br />
large-scale discovery: P11.064<br />
large-scale genomic data: P11.025<br />
Larsen: P02.153<br />
laryngeal and oropharyngeal cancer:<br />
P06.050<br />
laryngeal membrane: P03.177<br />
laryngomalacia: P02.060<br />
LAT2: P13.29<br />
late diabetic microvascular complication:<br />
P17.03<br />
Late onset: P09.024<br />
LATS2: P06.051<br />
Laurin-Sandrow Syndrome: P02.154<br />
Laurin-Sandrow syndrome: PL2.4<br />
LBSL: P02.203<br />
LCT: P09.067<br />
LDLR gene: P17.48<br />
LDLR: P17.49<br />
L-Dopa Selegiline therapy: P14.18<br />
Lead: P03.039<br />
Leber: P12.103<br />
Leber’s hereditary optic atrophy: P12.082<br />
left ventricular noncompaction: P16.28<br />
legal status: P01.24<br />
Leigh-syndrome: P02.061, P13.30<br />
LEOPARD syndrome: P02.135, P02.139<br />
LEOPARD: P02.138<br />
LEP: P10.01<br />
leptin receptor: P05.15, P09.089, P17.30<br />
leptin: P05.14, P08.39, P09.089, P17.30<br />
Lesch-Nyhan syndrome: P12.104<br />
lethal skeletal dysplasia: P02.151<br />
leucoencephalopathy: P02.062<br />
leukodystrophy: P12.113<br />
leukoencephalopathy: P02.203<br />
Lewy Body Dementia: P09.106<br />
LGMD2A: P16.45<br />
LGMD2F: P14.12<br />
LHON: P02.063, P02.064<br />
Li Fraumeni Syndrome (LFS): P06.052<br />
Li-Fraumeni syndrome: P06.053, S08.2<br />
Liguidators the Accident: P07.02<br />
Limb Body Wall Complex: P05.16<br />
limb girdle muscular dystrophy: P16.30<br />
limb malformation: P02.155<br />
Limb reduction defects: P02.156<br />
limb: P02.008<br />
limb-girdle muscular dystrophy: P16.46<br />
limitation <strong>of</strong> tongue movement: P02.051<br />
Linkage Analysis: P08.47, P10.32<br />
linkage disequilibrium: P08.40<br />
linkage power: P08.41<br />
Linkage: P08.34, P08.35, P08.40, P12.032<br />
Lipid pr<strong>of</strong>ile: P17.18<br />
lipid-associated disorders: PL1.1<br />
liposarcoma: P06.033<br />
Lithuanian cohort: P09.056<br />
liver cirrhosis: P10.27<br />
liver disease: P02.126, P13.25<br />
Liver fibrosis: P11.053<br />
Liver malformation: P02.024<br />
LMBRD1: P13.08<br />
LMNA: P02.100<br />
LN metastases: P06.134<br />
Lobular breast cancer: P06.036<br />
locus identification: C04.5<br />
locus-specific mutation database: P11.065<br />
Loeys-Dietz Syndromes: P02.065<br />
Long QT syndrome (LQTS): P16.29<br />
Long QT syndrome: P16.15<br />
longevity: P09.074<br />
loss <strong>of</strong> heterozygosity: P06.015, P06.101<br />
loss <strong>of</strong> imprinting: P04.17<br />
loss <strong>of</strong> methylation: P11.068<br />
LOVD: P11.065<br />
Low HDL: C10.2<br />
low penetrance genes: C06.4<br />
LQTS: P16.19<br />
LRP1: P08.06<br />
LRPAP1: P08.06<br />
LRTOMT: C14.3<br />
LS32: P15.07<br />
LSDBs: P11.102<br />
luciferase: P11.103<br />
lung cancer: P07.07<br />
LV hypertrophy: P09.013<br />
lymphocytes: P10.42<br />
lymphoproliferations: P06.092<br />
Lynch syndrome: P06.145, P06.147,<br />
P06.149, P06.150, P06.151, S13.2<br />
lysinuric protein intolerance: P12.105,<br />
P12.134<br />
lysinuric protein-intolerance: P12.106<br />
Lysosomal enzymes: P13.31<br />
Lysosomal starage disorders: P13.13<br />
Lysosomal Storage Diseases: P13.31<br />
lysosomal storage disorder: P05.21<br />
m<br />
macro ncRNAs: P11.028<br />
Madeira Island: P10.02<br />
Madeira population: P10.07<br />
major depression: P09.068<br />
major depressive disorder: C05.2,<br />
P09.069, P09.070<br />
Mal de Meleda: P12.107<br />
malaria: P10.51<br />
male infertility: P02.119, P03.187,<br />
P03.188, P03.191, P03.192, P03.193,<br />
P03.194, P03.198, P11.066<br />
Male Syndrome: P03.200<br />
malformations: P03.048, P03.073